Product Images Olanzapine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Olanzapine NDC 69543-385 by Virtus Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fig 1 1

fig 1 1

NDC 69543-380-30 is a medication called Olanzapine Tablets, USP, which should be dispensed with a Medication Guide to each patient. Patients should keep this medication and all drugs out of reach of children. The text includes a warning that the medication should be used only with a prescription. However, the rest of the text is garbled output and is not available for interpretation.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg (30 Tablets Bottle) - fig 1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg (30 Tablets Bottle) - fig 1

fig 2 1

fig 2 1

This is a description of a medication called Olanzapine Tablets, USP. The tablets contain 5 mg of carzapie, USP and the recommended dosage is not available due to missing text. The NDC number is 69543-381-30. The pharmacist is instructed to give a medication guide to each patient and to keep the drugs out of reach of children. It is only available with a prescription and produced by the manufacturer Virtus.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg (30 Tablets Bottle) - fig 2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg (30 Tablets Bottle) - fig 2

fig 3 1

fig 3 1

This is a description of a medication called Olanzapine Tablets, USP with National Drug Code (NDC) number 69543-382-30. The pharmacist is instructed to dispense the medication guide to each patient and to keep this and all drugs out of reach. The medication contains 75mg of chnzapie, USP. The text mentions gradual dosage and the name of the manufacturer, Qi PrarmacoubalCo L, located in France. There is also a reference to a safety code: GFCHLOREN, and the trade name of the medication, VIRTUS. The rest of the text is not readable and contains errors.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 7.5 mg (30 Tablets Bottle) - fig 3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 7.5 mg (30 Tablets Bottle) - fig 3

This appears to be a label/safety information for a medication called Olanzapine Tablets, with a dosage of 7.5 mg per tablet. The medication guide is to be given to each patient by the pharmacist, and the medication should be kept out of the reach of children.*

fig 4 1

fig 4 1

This appears to be a description of a medication called Olanzapine Tablets, USP with a dosage of 10 mg. The medication should be dispensed at night in a resistant container and the pharmacist should provide a medication guide to the patient. The text also includes a National Drug Code (NDC) and some information about the manufacturer. The bottom of the text includes instructions for pharmacists to keep the medication out of reach of children.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Tablets Bottle) - fig 4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Tablets Bottle) - fig 4

This text is a medication label and contains important information about the drug Olanzapine Tablets USP. It states that each tablet contains 10mg of Arzapi USP and provides the NDC number for the drug. Additionally, it instructs the pharmacist to dispense the accompanying medication guide to each patient and advises keeping the medication out of reach of others. The last line is not readable and appears to contain gibberish.*

fig 5 1

fig 5 1

Each tablet contains 15 mg of Canzapine, USP. The recommended dosage is 520mg, with accompanying instructions. The tablets are manufactured by O PharmacouCo and have an NDC of 69543-384-30. They are Olanzapine tablets, used to manage psychotic conditions. A medication guide should be dispensed to each patient and the drug should be kept away from children.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (30 Tablets Bottle) - fig 5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (30 Tablets Bottle) - fig 5

This is a description for Olanzapine Tablets. Pharmacists are advised to dispense a medication guide to each patient. The drug should be kept out of reach from others and protected from light and moisture. The rest of the text is not readable.*

fig 6 1

fig 6 1

This is a medication label for Olanzapine Tablets, USP, with a dosage of 20mg. The pharmacist is advised to dispense the accompanying medication guide to each patient and to keep it out of the reach of children. The label includes a unique identification number NDC69543-385-30. The text 'S crs 20m ot s, U KEEP TN GL0SED Byt se ¥t sl broken et o b and ot' is not clearly readable.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (30 Tablets Bottle) - fig 6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (30 Tablets Bottle) - fig 6

This is a medication label for Olanzapine Tablets, USP. It includes a warning to keep the medication tightly closed and out of the reach of children. The pharmacist is advised to dispense the accompanying medication guide to each patient. The label also includes an NDC number and a company name, VIRTUS®.*

image description - olanzapine str

image description - olanzapine str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.